研報掘金丨方正證券:匯川技術業績穩健增長 維持“推薦”評級
方正證券研報指出,匯川技術(300124.SZ)為工控行業龍頭企業,戰略+管理+技術打造優秀多元化產品平台。公司管理團隊大多曾就職華為、艾默生,兼具國際化與專業背景,此外,自公司上市以來連續發佈多輪股權激勵,持續激發經營活力。前瞻判斷、優秀管理能力以及產品力塑造公司核心競爭力。公司憑藉優秀戰略定位、管理能力及產品力實現產品多元化佈局,多年來業績穩健增長,市佔率穩步提升。看好製造業復甦,以及新能源車產品放量背景下公司未來前景,維持“推薦”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.